返回 Agenda
Session Chair(s)
Jerald Schindler, DrPH
Chief Executive Officer
Strategic Statistics, United States
Rajeshwari Sridhara, PHD
Senior Biostatistician Consultant, Oncology Center of Excellence, FDA
FDA, United States
Speaker(s)
FDA Oncology Experience in Innovative Adaptive Trial Designs
Rajeshwari Sridhara, PHD
FDA, United States
Senior Biostatistician Consultant, Oncology Center of Excellence, FDA
Adaptive Population Enrichment for Oncology Trials
Cyrus R. Mehta, PHD, MSC
Cytel Inc., United States
Founder and President
Panelist
Lisa LaVange, PHD
University of North Carolina at Chapel Hill, United States
Professor Emerita